Defilade Capital Management, L.P. — 13F Holdings & Portfolio
CIK 2088557 · latest 13F-HR filed 2026-08-14
Defilade Capital Management, L.P. manages $746.9M in 13F-reported U.S. long-equity assets across 39 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are LLY (6.28%), PFE (5.71%), VEEV (5.62%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 20 new positions, exited 12, added to 6, and trimmed 10.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
SUITE 625
EMERYVILLE, CA 94608
$746.9M
Long-equity book
39
Distinct positions
2026-06-30
Filed 2026-08-14
+20 / −12 / ↑6 / ↓10
vs 2026-03-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- ELI LILLY & CO$27.8M +146.3%
- PTC THERAPEUTICS INC$9.7M +38.0%
- ELEDON PHARMACEUTICALS INC$2.9M +26.5%
- OCULAR THERAPEUTIX INC$2.0M +16.1%
- COGENT BIOSCIENCES INC$1.7M +12.2%
Top Trims
- ZIMMER BIOMET HOLDINGS INC-$25.0M -47.8%
- GLOBUS MED INC-$19.5M -63.9%
- ICU MED INC-$17.3M -52.8%
- DENALI THERAPEUTICS INC-$16.0M -61.4%
- REVOLUTION MEDICINES INC-$15.2M -49.5%
New Positions
- VEEVA SYS INC$42.0M
- BIOMARIN PHARMACEUTICAL INC$39.0M
- BAXTER INTL INC$31.1M
- INSULET CORP$26.9M
- THERMO FISHER SCIENTIFIC INC$26.0M
Exited Positions
- SCHEIN HENRY INC$46.0M
- BECTON DICKINSON & CO$43.9M
- DEXCOM INC$33.8M
- INTUITIVE SURGICAL INC$31.2M
- NEUROCRINE BIOSCIENCES INC$27.7M
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | ELI LILLY & CO | LLY | 532457108 | $46.9M | 6.28% | 39,086 | SH |
| 2 | PFIZER INC | PFE | 717081103 | $42.7M | 5.71% | 1,771,743 | SH |
| 3 | VEEVA SYS INC | VEEV | 922475108 | $42.0M | 5.62% | 236,709 | SH |
| 4 | BIOMARIN PHARMACEUTICAL INC | BMRN | 09061G101 | $39.0M | 5.22% | 682,005 | SH |
| 5 | PTC THERAPEUTICS INC | PTCT | 69366J200 | $35.4M | 4.74% | 433,699 | SH |
| 6 | BAXTER INTL INC | BAX | 071813109 | $31.1M | 4.17% | 1,459,380 | SH |
| 7 | INSMED INC | INSM | 457669307 | $30.0M | 4.02% | 281,838 | SH |
| 8 | ZIMMER BIOMET HOLDINGS INC | ZBH | 98956P102 | $27.3M | 3.66% | 317,426 | SH |
| 9 | INSULET CORP | PODD | 45784P101 | $26.9M | 3.61% | 176,932 | SH |
| 10 | THERMO FISHER SCIENTIFIC INC | TMO | 883556102 | $26.0M | 3.49% | 51,934 | SH |
| 11 | ABBOTT LABORATORIES | ABT | 002824100 | $25.9M | 3.47% | 285,778 | SH |
| 12 | ASCENDIS PHARMA A/S | ASND | K08588103 | $25.3M | 3.39% | 94,843 | SH |
| 13 | SOLVENTUM CORP | SOLV | 83444M101 | $24.4M | 3.27% | 316,454 | SH |
| 14 | MEDTRONIC PLC | MDT | G5960L103 | $23.7M | 3.18% | 303,301 | SH |
| 15 | ELANCO ANIMAL HEALTH INC | ELAN | 28414H103 | $21.3M | 2.85% | 864,080 | SH |
| 16 | AGIOS PHARMACEUTICALS INC | AGIO | 00847X104 | $20.3M | 2.72% | 546,848 | SH |
| 17 | ENVISTA HOLDINGS CORPORATION | NVST | 29415F104 | $19.1M | 2.56% | 726,108 | SH |
| 18 | REVOLUTION MEDICINES INC | RVMD | 76155X100 | $15.5M | 2.08% | 82,827 | SH |
| 19 | ICU MED INC | ICUI | 44930G107 | $15.5M | 2.07% | 105,700 | SH |
| 20 | COGENT BIOSCIENCES INC | COGT | 19240Q201 | $15.2M | 2.04% | 393,441 | SH |
| 21 | LANTHEUS HLDGS INC | LNTH | 516544103 | $14.7M | 1.97% | 132,662 | SH |
| 22 | OCULAR THERAPEUTIX INC | OCUL | 67576A100 | $14.6M | 1.96% | 1,490,286 | SH |
| 23 | ELEDON PHARMACEUTICALS INC | ELDN | 28617K101 | $13.9M | 1.86% | 3,525,338 | SH |
| 24 | TYRA BIOSCIENCES INC | TYRA | 90240B106 | $12.0M | 1.61% | 376,870 | SH |
| 25 | OLEMA PHARMACEUTICALS INC | OLMA | 68062P106 | $11.6M | 1.55% | 924,758 | SH |
| 26 | ORIC PHARMACEUTICALS INC | ORIC | 68622P109 | $11.3M | 1.52% | 1,047,690 | SH |
| 27 | LARIMAR THERAPEUTICS INC | LRMR | 517125100 | $11.2M | 1.50% | 3,670,135 | SH |
| 28 | GLOBUS MED INC | GMED | 379577208 | $11.0M | 1.48% | 139,637 | SH |
| 29 | ENOVIS CORPORATION | ENOV | 194014502 | $11.0M | 1.47% | 531,945 | SH |
| 30 | EVOMMUNE INC | EVMN | 30054Y107 | $10.5M | 1.41% | 793,145 | SH |
| 31 | TELEFLEX INCORPORATED | TFX | 879369106 | $10.2M | 1.36% | 80,118 | SH |
| 32 | DENALI THERAPEUTICS INC | DNLI | 24823R105 | $10.1M | 1.35% | 391,866 | SH |
| 33 | GLAUKOS CORP | GKOS | 377322102 | $9.3M | 1.24% | 66,519 | SH |
| 34 | STAAR SURGICAL CO | STAA | 852312305 | $9.2M | 1.24% | 322,126 | SH |
| 35 | PACS GROUP INC | PACS | 69380Q107 | $9.2M | 1.23% | 215,675 | SH |
| 36 | CRINETICS PHARMACEUTICALS IN | CRNX | 22663K107 | $9.0M | 1.20% | 239,440 | SH |
| 37 | LIVANOVA PLC | LIVN | G5509L101 | $8.8M | 1.18% | 107,373 | SH |
| 38 | BLACK DIAMOND THERAPEUTICS I | BDTX | 09203E105 | $3.1M | 0.41% | 1,674,999 | SH |
| 39 | MEREO BIOPHARMA GROUP PLC | MREO | 589492107 | $2.4M | 0.32% | 7,558,756 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | $746.9M | 39 | 0002088557-26-000008 |
| 2026-03-31 | 2026-05-14 | $712.2M | 31 | 0002088557-26-000005 |
| 2026-03-31 | 2026-06-12 | $712.2M | 31 | 0002088557-26-000006 |
| 2025-12-31 | 2026-02-13 | $737.7M | 33 | 0002088557-26-000002 |